Proteomic characterization of novel serum amyloid P component variants from human plasma and urine.
about
Identification of calcium-binding proteins associated with the human sperm plasma membraneIsotope-differentiated binding energy shift tags (IDBEST) for improved targeted biomarker discovery and validation.Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesExamining serum amyloid P component microheterogeneity using capillary isoelectric focusing and MALDI-MSBuilding multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneityInvestigating diversity in human plasma proteinsTargeted quantitative mass spectrometric immunoassay for human protein variants.Population proteomics: addressing protein diversity in humans.Population proteomics: the concept, attributes, and potential for cancer biomarker research.Mass spectrometry-based immunoassays for the next phase of clinical applications.Multiplexed surrogate analysis of glycotransferase activity in whole biospecimensQuantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation.Glycosylation status of vitamin D binding protein in cancer patients.Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Biomarker rediscovery in diagnostics.Human proteoforms as new targets for clinical mass spectrometry protein tests.Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model.Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes.
P2860
Q30437039-04AC5003-9A48-4D51-B228-308DA5FAD38CQ33217472-60DEAB24-7143-40FE-BC1A-9E9F6C43ECFAQ33643266-C7EF0ED1-2E27-487E-8535-9CF1480FBFE4Q33779346-823EFF65-CDAC-4251-9D4B-C04C6E6BB34AQ33845667-1C602DFB-E598-4A12-9FB4-166C567F3A21Q33905685-02BA2CD4-8C2A-4F77-8C41-56231BA5985EQ34825391-1212B121-70B4-4E96-A348-5BA3EBA79844Q36184782-5276BC4C-EE9A-4AB0-B9D6-90B5A8897D41Q36492806-A40CA3B3-CEFF-4898-B6F8-EAAD3C8D92DAQ36689104-3C83C44B-FA6C-44FE-AE31-12F0E36A8DA5Q36833668-D526ECB6-728D-4B2C-A5ED-0D11612F40FBQ36841893-8F9BAEEE-E37C-44F9-A5B0-A35CDF7ED256Q37137667-5D4E4F64-B2D4-41BE-B876-94382AB90B63Q37452925-A329121D-6570-48BF-B0FA-92A749B17CD7Q37566426-82DF1A3E-D517-4E5C-886F-2809BE45E624Q38089951-4DB35920-B612-4AD8-BFD8-8FD26588F0BDQ38649742-3AAFAE7A-3388-4C8F-9C7E-37C8461AD7AAQ42100819-7E6687B9-0579-4153-B496-79661FDC15DEQ43789293-D16FD8FA-BFD4-4561-B772-51128DE95C77Q47163663-3EAA7043-56CD-4CD8-B4E2-1C11866F86D3
P2860
Proteomic characterization of novel serum amyloid P component variants from human plasma and urine.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Proteomic characterization of ...... s from human plasma and urine.
@ast
Proteomic characterization of ...... s from human plasma and urine.
@en
type
label
Proteomic characterization of ...... s from human plasma and urine.
@ast
Proteomic characterization of ...... s from human plasma and urine.
@en
prefLabel
Proteomic characterization of ...... s from human plasma and urine.
@ast
Proteomic characterization of ...... s from human plasma and urine.
@en
P2093
P356
P1433
P1476
Proteomic characterization of ...... s from human plasma and urine.
@en
P2093
Dobrin Nedelkov
Eric E Niederkofler
Kemmons A Tubbs
Randball W Nelson
Urban A Kiernan
P304
P356
10.1002/PMIC.200300690
P577
2004-06-01T00:00:00Z